Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$10,075 Mln
Revenue (TTM)
$13,643 Mln
Net Profit (TTM)
$747 Mln
ROE
0.6 %
ROCE
5.6 %
P/E Ratio
15.8
P/B Ratio
21.6
Industry P/E
--
EV/EBITDA
8.5
Div. Yield
0 %
Debt to Equity
-23.1
Book Value
$--
EPS
$8.5
Face value
--
Shares outstanding
66,849,000
CFO
$18,269.91 Mln
EBITDA
$22,956.97 Mln
Net Profit
$7,349.22 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
DaVita HealthCare Partners Inc (DVA)
| 31.0 | -1.1 | 25.7 | -0.3 | 24.7 | 6.7 | 7.7 |
|
BSE Sensex*
| -12.4 | -11.4 | -12.2 | -1.5 | 8.6 | 8.6 | 11.5 |
|
S&P Midcap 400
| 0.5 | -5.8 | 1.7 | 13.2 | 12.3 | 4.8 | 9.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
DaVita HealthCare Partners Inc (DVA)
| -24.0 | 42.3 | 40.3 | -34.4 | -3.1 | 56.5 | 45.8 |
|
S&P Midcap 400
| 5.9 | 12.1 | 14.4 | -14.5 | 23.2 | 11.8 | 24.1 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
DaVita HealthCare Partners Inc (DVA)
|
148.8 | 10,075.5 | 13,643.1 | 746.8 | 14.1 | -281.8 | 15.8 | 21.6 |
| 73.0 | 96,853.4 | 402,067.0 | 1,768.0 | 1.3 | 2.3 | 54.8 | 1.3 | |
| 99.7 | 10,098.8 | 5,935.2 | 566.2 | 18.1 | 25.1 | 18.1 | 4.1 | |
| 502.1 | 119,183.9 | 75,600.0 | 6,784.0 | 16.0 | -159.1 | 18.8 | 293.4 | |
| 265.8 | 21,869.0 | 13,951.7 | 876.5 | 9.5 | 10.5 | 25.2 | 2.5 | |
| 197.8 | 26,624.2 | 2,306.1 | -208.2 | -11.2 | -14.3 | -- | 15.5 | |
| 195.2 | 22,215.1 | 11,035.0 | 992.0 | 13.2 | 14.2 | 22.8 | 3.1 | |
| 203.2 | 20,005.3 | 21,310.0 | 1,407.0 | 16.9 | 33.5 | 14.7 | 4.6 | |
| 205.0 | 12,186.8 | 5,057.8 | 344.0 | 9.2 | 16.9 | 36 | 5.5 | |
| 189.6 | 11,754.3 | 17,364.8 | 1,488.8 | 12.2 | 21.4 | 8.3 | 1.6 |
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers... outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. Read more
CEO & Executive Director
Mr. Javier J. Rodriguez
CEO & Executive Director
Mr. Javier J. Rodriguez
Headquarters
Denver, CO
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of DaVita HealthCare Partners Inc (DVA) is $148.83 (NYSE) as of 18-Mar-2026 16:00 EDT. DaVita HealthCare Partners Inc (DVA) has given a return of 24.69% in the last 3 years.
The P/E ratio of DaVita HealthCare Partners Inc (DVA) is 15.85 times as on 13-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
13.40
|
-15.37
|
|
2024
|
13.70
|
105.93
|
|
2023
|
14.06
|
9.20
|
|
2022
|
12.25
|
9.63
|
|
2021
|
12.19
|
15.79
|
The 52-week high and low of DaVita HealthCare Partners Inc (DVA) are Rs 159.39 and Rs 102.26 as of 19-Mar-2026.
DaVita HealthCare Partners Inc (DVA) has a market capitalisation of $ 10,075 Mln as on 13-Mar-2026. As per SEBI classification, it is a Mid Cap company.
Before investing in DaVita HealthCare Partners Inc (DVA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-1.15
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.